SanaClis heading for THREE EVENTS IN JUNE 2018

Bratislava, Slovakia

Award-winning full service CRO SanaClis has announced plans to attend three leading clinical trials-oriented and pharmaceutical events on both sides of the Atlantic during June 2018.

SanaClis will appear at the Clinical Trial Supply Chain Strategy Meeting in Boston, the Global Generic, Biosimilar and Value-Added Medicines Conference in Budapest and the German ePharma Day in Frankfurt. It will use its presence at all three events to strengthen relationships with its core customer base of pharma and biotech decision makers within clinical operations, clinical development, supply chain and data management.

The first event attended will be the Clinical Trial Supply Chain Strategy Meeting, a one-day event tailored to the needs of director-level executives involved in clinical trial supply chain issues. The meeting will be held June 13th at The Sheraton, Boston Harbor and organized by Proventa International.

In Boston, SanaClis team will be led by Managing Partner Alexander Fetkovsky, who has extensive experience in the CRO and cold chain management industry and carries overall responsibility for the planning and execution of strategic initiatives and business partnering, as well as operational and financial oversight for multiple clinical programs and clinical trial supply/warehouse operations.

“The CTS Chain Strategy Meeting should give us a great platform from which to share expertise, present our services, network with industry professionals and decision makers of established and emerging pharma, biotech companies and participate in in-depth discussions of clinical trials and supply chain trends,” said Mr. Fetkovsky.

From Boston moving to Budapest, where SanaClis team will attend the Global Generic, Biosimilar and Value Added Medicines Conference.

This three-day event, which also opens June 13th at the Hilton Budapest, combines the 24th Medicines for Europe and 21st IGBA Annual Conferences.

“This is the first time we have attended this event, moreover we are pleased to join the experts’ discussions as a member of Medicines for Europe,” said Mr. Fetkovsky.

“The fact that this event is held in Budapest is particularly valuable for us. Since Central and Eastern Europe is where SanaClis has its roots and built its clinical trial supports networks,” he added.

The following week, SanaClis will also be present at German ePharma Day, held on June 19th at the InterCity Hotel at Frankfurt Airport, Germany.

SanaClis CEO, Dr. Vladimir Misik, has been invited to present results of his research on “Latest Geographic Trends in Global Industry Clinical Trials: who is winning, who is losing?” drawing on his more than 30 years’ experience in biopharmaceutical research and development. Dr. Misik is also author and co-author of more than 60 research articles and book chapters in peer-reviewed journals, including several recent publications on globalization of clinical trials.

“German ePharma Day will give us the opportunity to illustrate changing landscape of global industry clinical trials and thee key drivers,” said Dr. Misik.